Abbott Laboratories Sales Rise, Lifts Full-Year Outlook -- Earnings Review
July 18 2018 - 8:44AM
Dow Jones News
By Aisha Al-Muslim
Abbott Laboratories (ABT) reported its second-quarter results
before the opening of trading Wednesday. Here's what you need to
know.
PROFIT: Net income for the global health-care company was $733
million, or 41 cents a share, compared with $283 million, or 16
cents a share, for the same quarter a year before. Adjusted
earnings were 73 cents a share, beating the 71 cents a share
analysts polled by Thomson Reuters were looking for.
REVENUE: Net sales rose 17% to $7.77 billion, ahead of the
consensus forecast of $7.71 billion.
GUIDANCE: For 2018, the company raised its guidance for adjusted
earnings per share to between $2.85 and $2.91 from between $2.80 to
$2.90. Analysts had forecast adjusted earnings of $2.86 a
share.
For the third quarter, the company guided adjusted earnings per
share between 73 cents and 75 cents, compared with analysts'
estimates of 74 cents a share.
STOCK MOVE: Shares rose 1.9% to $64 in premarket trading
Wednesday. Shares are up 29% in the last year.
Write to Aisha Al-Muslim at aisha.al-muslim@wsj.com
(END) Dow Jones Newswires
July 18, 2018 08:29 ET (12:29 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Apr 2024 to May 2024
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From May 2023 to May 2024